Panmira Pharmaceuticals is Drug Discovery in United States that focus on small molecule business. Founded in 2011. They cover business area such as developer, pharmaceutical product, multiple allergic and inflammatory condition, small molecule pharmaceutical therapy, inflammatory disease, asthma, chronic obstructive pulmonary disease, eosinophillic esophagitis.
2011
( 13 years old in 2024 )
Small Molecule
-
P.O. Box 81946
San Diego, CA 92138
United States
Private
developerpharmaceutical productmultiple allergic and inflammatory conditionsmall molecule pharmaceutical therapyinflammatory diseaseasthmachronic obstructive pulmonary diseaseeosinophillic esophagitis
* We use standard office opening hours in near Panmira Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Panmira Pharmaceuticals is Drug Discovery business from United States that founded in 2011 (13 years old in 2024), Panmira Pharmaceuticals business is focusing on Small Molecule.
Panmira Pharmaceuticals headquarter office and corporate office address is located in P.O. Box 81946 San Diego, CA 92138 United States.
Panmira Pharmaceuticals was founded in United States.
In 2024, Panmira Pharmaceuticals is currently focus on small molecule sector.
Above is snippet of Google Trends for "small molecule" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Panmira Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
